Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 27 3 2020
pubmed: 27 3 2020
medline: 31 10 2020
Statut: ppublish

Résumé

We report the third outbreak of pneumococcal pneumonia within one year among workers in European shipyards. During January and February 2020, 37 cases of pneumonia were identified in a shipyard in Marseille, south-eastern France. Outbreak control measures were implemented, including a mass vaccination campaign with 23-valent pneumococcal polysaccharide vaccine targeting all shipyard workers. Given the high mobility of shipyard workers, coordinated responses between European public health institutes are necessary to avoid further outbreaks.

Identifiants

pubmed: 32209166
doi: 10.2807/1560-7917.ES.2020.25.11.2000162
pmc: PMC7096773
doi:

Substances chimiques

Pneumococcal Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Occup Med (Lond). 2012 Jul;62(5):325-30
pubmed: 22764269
J Infect. 2019 Dec;79(6):495-502
pubmed: 31629865
Nat Rev Microbiol. 2018 Jun;16(6):355-367
pubmed: 29599457
Respiration. 2017;94(3):299-311
pubmed: 28738364
J Infect. 2020 May;80(5):578-606
pubmed: 31891730
Int J Infect Dis. 2010 Sep;14(9):e796-9
pubmed: 20637673
Int J Antimicrob Agents. 2017 Oct;50(4):505-506
pubmed: 28669834
Euro Surveill. 2019 Dec;24(49):
pubmed: 31822326
Vaccine. 2017 Jul 13;35(32):3945-3950
pubmed: 28633889
Vaccine. 2015 Jan 3;33(2):359-66
pubmed: 25448105
Curr Opin Infect Dis. 2017 Apr;30(2):201-207
pubmed: 27984245

Auteurs

Nadim Cassir (N)

University Hospital Institute -Méditerranée Infection (IHU), Marseille, France.
Aix Marseille University, IRD, AP-HM, MEPHI, Marseille, France.
These authors contributed equally to this work.

Laurence Pascal (L)

These authors contributed equally to this work.
French National Public Health Agency (Santé publique France), Marseille, France.

David Ferrieux (D)

University Hospital Institute -Méditerranée Infection (IHU), Marseille, France.

Christiane Bruel (C)

Regional Health Agency of Provence-Alpes-Côte d'Azur (ARS Paca), Marseille, France.

Christophe Guervilly (C)

Service de Médecine Intensive - Réanimation, APHM, Hôpital Nord, Marseille, France.
Center for Studies and Research on Health Services and Quality of Life (CEReSS), Aix-Marseille University, Marseille, France.

Stanislas Rebaudet (S)

Hôpital Européen, SESSTIM, Aix-Marseille Univ, INSERM, IRD, Marseille, France.

Kostas Danis (K)

French National Public Health Agency (Santé publique France), Saint Maurice, France.

Lora Kopec (L)

University Hospital Institute -Méditerranée Infection (IHU), Marseille, France.
Aix Marseille University, IRD, AP-HM, MEPHI, Marseille, France.

Florence Fenollar (F)

University Hospital Institute -Méditerranée Infection (IHU), Marseille, France.
Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.

Emmanuelle Varon (E)

National Reference Laboratory for pneumococcus, Créteil, France.

Véronique Vig (V)

Regional Health Agency of Provence-Alpes-Côte d'Azur (ARS Paca), Marseille, France.

Jean-Luc Lasalle (JL)

French National Public Health Agency (Santé publique France), Marseille, France.

Lauriane Ramalli (L)

French National Public Health Agency (Santé publique France), Marseille, France.

Pierre Michelet (P)

Service des Urgences Adultes, Hôpital de la Timone, UMR MD2, Aix-Marseille Université, Marseille, France.

Jean-Christophe Lagier (JC)

University Hospital Institute -Méditerranée Infection (IHU), Marseille, France.
Aix Marseille University, IRD, AP-HM, MEPHI, Marseille, France.

Nicolas Persico (N)

Service des Urgences Adultes, Hôpital Nord, Marseille, France.
Center for Studies and Research on Health Services and Quality of Life (CEReSS), Aix-Marseille University, Marseille, France.

Philippe Brouqui (P)

University Hospital Institute -Méditerranée Infection (IHU), Marseille, France.
Aix Marseille University, IRD, AP-HM, MEPHI, Marseille, France.

Philippe Malfait (P)

French National Public Health Agency (Santé publique France), Marseille, France.

Philippe Parola (P)

University Hospital Institute -Méditerranée Infection (IHU), Marseille, France.
Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH